系统性硬化症患者单核细胞中ATM活化水平降低
结果显示SSc患者单核细胞和中性粒细胞pATM表达显著低于健康对照,且单核细胞pATM降低与间质性肺病及数字凹陷性瘢痕相关,ATM特异性抑制剂可增强氧化应激下单核细胞活性氧产生。
要点
- SSc患者单核细胞和中性粒细胞pATM表达显著低于健康对照。
- SSc患者单核细胞pATM降低与间质性肺病和数字凹陷性瘢痕相关。
- ATM特异性抑制剂KU55933可增强氧化应激下单核细胞活性氧产生。
核心结论
- SSc患者单核细胞ATM活化降低与SSc相关间质性肺病有关,ATM活化受损可能通过失控的活性氧产生参与SSc疾病过程。
研究设计与样本
- 外周单核细胞用ATM特异性抑制剂KU55933培养,检测细胞内活性氧产生。
主要发现
- SSc患者外周单核细胞和中性粒细胞pATM表达水平显著低于健康对照(P=0.04和P<0.001),而总ATM表达在SSc与健康对照间无显著差异。
- 合并间质性肺病或数字凹陷性瘢痕的SSc患者单核细胞pATM表达分别显著低于无这些临床特征的患者(P=0.02和P=0.03)。
- SSc患者单核细胞pATM表达与用力肺活量正相关,与血清Krebs von den Lungen-6水平负相关。
- KU55933可增强氧化应激下单核细胞的活性氧产生。
关键数值与推荐
- SSc患者单核细胞pATM表达低于健康对照,P=0.04。
- SSc患者中性粒细胞pATM表达低于健康对照,P<0.001。
- 合并间质性肺病的SSc患者单核细胞pATM表达低于无间质性肺病者,P=0.02。
- 合并数字凹陷性瘢痕的SSc患者单核细胞pATM表达低于无此表现者,P=0.03。
临床怎么用
- 单核细胞pATM降低可能与SSc间质性肺病相关,提示ATM活化通路或可作为评估SSc肺部受累的探索性生物标志物。
- ATM活化受损导致活性氧产生失控的机制,为SSc氧化应激相关治疗策略提供了潜在研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The regulation system for oxidative stress in systemic sclerosis (SSc) remains unclear. This study aimed to clarify the possible involvement of ataxia telangiectasia mutated (ATM), which plays a key role in DNA repair and redox balance, in the pathogenesis of SSc. METHODS: Thirty patients with SSc and 15 healthy controls were enrolled. Expression of ATM and phosphorylated ATM (pATM), an activated form of ATM, in phagocytes in whole blood samples was analysed by FACS. Correlations between expression levels of ATM/pATM and clinical parameters of SSc patients were statistically analysed. Peripheral monocytes were cultured with an ATM-specific inhibitor (KU55933), and reactive oxygen species production in the cells was measured. RESULTS: Expression level of pATM in peripheral monocytes and neutrophils from SSc patients was significantly lower than those in healthy controls (P = 0.04 and P < 0.001, respectively), while no significant difference in total ATM expression was observed between SSc and healthy controls. In addition, pATM expression in monocytes of SSc patients with interstitial lung disease or digital pitting scar was remarkably lower than in the patients without these clinical features (P = 0.02 and P = 0.03), respectively. Moreover, pATM expression in monocytes positively correlated with forced vital capacity and negatively correlated with the serum Krebs von den Lungen-6 level. Notably, KU55933, an ATM-specific inhibitor, enhanced reactive oxygen species production by monocytes under oxidative stress. CONCLUSION: Our data revealed that decreased ATM activation in monocytes was associated with SSc-interstitial lung disease and that impaired ATM activation in monocytes may contribute to the disease process of SSc via uncontrolled reactive oxygen species production.
引用
- Sakata K, Yasuoka H, Yoshimoto K, et al. Decreased activation of ataxia telangiectasia mutated (ATM) in monocytes from patients with systemic sclerosis. Rheumatology (Oxford). 2020. PMID: 32743653. doi:10.1093/rheumatology/keaa312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。